Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term Assessment of the Safety and Efficacy of AMG 827 Subcutaneous Treatment in Subjects With Psoriasis

NCT01101100 is registered in ClinicalTrials.gov with Bausch Health Americas, Inc. as lead sponsor.

NCT NCT01101100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01101100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term Assessment of the Safety and Efficacy of AMG 827 Subcutaneous Treatment in Subjects With Psoriasis
Lead sponsor
Bausch Health Americas, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2010
Completion date
September 30, 2015
Enrollment
181 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis